Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Texas A&M Investment Management Company (TIMCO) is the dedicated investment organization responsible for managing the financial assets of the Texas A&M University System. Established in 2023, the company provides oversight for the system's multi-billion dollar portfolio, including the Permanent University Fund and the System Endowment Fund. TIMCO's primary mission is to achieve long-term capital appreciation and generate stable income to support the university's educational, research, and service initiatives. The organization manages a diversified portfolio across various asset classes, including public equities, private equity, fixed income, and alternative investments. While TIMCO may invest in life sciences and healthcare through its venture capital and private equity allocations, it is a financial management entity rather than a biotechnology developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Texas A&M Investment Management Company.